The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson’s disease

Agid, 1990, The biochemistry of Parkinson’s disease, 99

Firnau, 1987, Cerebral metabolism of 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine in the primate, J Neurochem, 48, 1077, 10.1111/j.1471-4159.1987.tb05629.x

Snow, 1993, Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels, Ann Neurol, 34, 324, 10.1002/ana.410340304

Brooks, 1990, The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson’s disease, studied with PET, Brain, 113, 1539, 10.1093/brain/113.5.1539

Leenders, 1986, Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography, J Neurol Neurosurg Psychiatry, 49, 853, 10.1136/jnnp.49.8.853

Vingerhoets, 1997, Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion?, Ann Neurol, 41, 58, 10.1002/ana.410410111

Brooks, 1990, Differing patterns of striatal 18F-Dopa uptake in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy, Ann Neurol, 28, 547, 10.1002/ana.410280412

Morrish, 1996, Regional changes in [18F]dopa metabolism in the striatum in Parkinson’s disease, Brain, 119, 2097, 10.1093/brain/119.6.2097

Brown, 1990, Cognition in Parkinson’s disease: from description to theory, Trends Neurosci, 13, 21, 10.1016/0166-2236(90)90058-I

Cooper, 1991, Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability, Brain, 114, 2095, 10.1093/brain/114.5.2095

Dubois, 1997, Cognitive deficits in Parkinson’s disease, J Neurol, 244, 2, 10.1007/PL00007725

Dubois, 1988, Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson’s disease, Arch Neurol, 45, 1194, 10.1001/archneur.1988.00520350032011

Dubois, 1990, Age-induced cognitive disturbances in Parkinson’s disease, Neurology, 40, 38, 10.1212/WNL.40.1.38

Gotham, 1986, Depression in Parkinson’s disease: a quantitative and qualitative analysis, J Neurol Neurosurg Psychiatry, 49, 381, 10.1136/jnnp.49.4.381

Lees, 1983, Cognitive deficits in the early stages of Parkinson’s disease, Brain, 106, 257, 10.1093/brain/106.2.257

Levin, 1989, Cognitive impairments associated with early Parkinson’s disease, Neurology, 39, 557, 10.1212/WNL.39.4.557

Levin, 1992, Cognitive impairments in Parkinson’s disease, Neurol Clin, 10, 471, 10.1016/S0733-8619(18)30222-6

Owen, 1993, Fronto-striatal cognitive deficits at different stages of Parkinson’s disease, Brain, 115, 1727, 10.1093/brain/115.6.1727

Taylor, 1986, Frontal lobe dysfunction in Parkinson’s disease, Brain, 109, 845, 10.1093/brain/109.5.845

Alexander, 1990, Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci, 13, 266, 10.1016/0166-2236(90)90107-L

Brown, 1984, Alterations in cognitive performance and affect arousal state during fluctuations in motor function in Parkinson’s disease, J Neurol Neurosurg Psychiatry, 47, 454, 10.1136/jnnp.47.5.454

Stern, 1985, Intellectual changes in patients with MPTP-induced parkinsonism, Neurology, 35, 1506, 10.1212/WNL.35.10.1506

Pillon, 1989, Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions?, J Neurol Neurosurg Psychiatry, 52, 201, 10.1136/jnnp.52.2.201

Spicer, 1988, Neuropsychological performance in lateralized parkinsonism, Arch Neurol, 45, 429, 10.1001/archneur.1988.00520280079019

Tomer, 1993, Side of onset of motor symptoms influences cognition in Parkinson’s disease, Ann Neurol, 34, 579, 10.1002/ana.410340412

Garcia-Larrea, 1996, Brain responses to detection of right or left somatic targets are symmetrical in unilateral Parkinson’s disease. A case against the concept of ‘parkinsonian neglect’, Cortex, 32, 679, 10.1016/S0010-9452(96)80038-4

Tachibana, 1997, P3 latency change in aging and Parkinson’s disease, Arch Neurol, 54, 296, 10.1001/archneur.1997.00550150054016

Girotti, 1986, Motor and cognitive performances of Parkinsonian patients in the ‘on’ and ‘off’ phases of the disease, J Neurol Neurosurg Psychiatry, 49, 657, 10.1136/jnnp.49.6.657

Gotham, 1988, ‘Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa, Brain, 111, 299, 10.1093/brain/111.2.299

Malapani, 1994, Impaired simultaneous cognitive task performance in Parkinson’s disease: a dopamine-related dysfunction, Neurology, 44, 319, 10.1212/WNL.44.2.319

Pillon, 1989, Cognitive ‘slowing’ in Parkinson’s disease fails to respond to levodopa treatment: the ‘fifteen objects test’, Neurology, 39, 762, 10.1212/WNL.39.6.762

Prasher, 1991, Dopaminergic induced changes in cognitive and motor processing in Parkinson’s disease: an electrophysiological investigation, J Neurol Neurosurg Psychiatry, 54, 603, 10.1136/jnnp.54.7.603

Rafal, 1984, Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson’s disease, Brain, 107, 1083, 10.1093/brain/107.4.1083

Stanzione, 1991, P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300, Electroencephalogr Clin Neurophysiol, 80, 446, 10.1016/0168-5597(91)90093-D

Dubois, 1990, Cholinergic deficiency and frontal dysfunction in Parkinson’s disease, Ann Neurol, 28, 117, 10.1002/ana.410280202

Holthoff-Detto, 1997, Functional effects of striatal dysfunction in Parkinson’s disease, Arch Neurol, 54, 145, 10.1001/archneur.1997.00550140025008

Acton, 1997, Registration of dynamic dopamine D2 receptor images using principal component analysis, Eur J Nucl Med, 24, 1405, 10.1007/s002590050167

Boles, 1996, Factor analysis and the cerebral hemispheres: ‘unlocalized’ functions, Neuropsychologia, 34, 723, 10.1016/0028-3932(95)00136-0

Chapman, 1995, EP component identification and measurement by principal components analysis, Brain Cogn, 27, 288, 10.1006/brcg.1995.1024

Eidelberg, 1994, The metabolic topography of parkinsonism, J Cereb Blood Flow Metab, 14, 783, 10.1038/jcbfm.1994.99

Gibb, 1988, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease, J Neurol Neurosurg Psychiatry, 51, 745, 10.1136/jnnp.51.6.745

Fahn, 1987, Unified Parkinson’s disease rating scale, 153

Langston, 1992, Core assessment program for intracerebral transplantations (CAPIT), Mov Disord, 7, 2, 10.1002/mds.870070103

Coblentz, 1973, Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics, Arch Neurol, 29, 299, 10.1001/archneur.1973.00490290039003

El-Awar, 1987, Learning deficit in Parkinson’s disease. Comparison with Alzheimer’s disease and normal aging, Arch Neurol, 44, 180, 10.1001/archneur.1987.00520140048016

Schmidt, 1994, The Mattis Dementia Rating Scale: normative data from 1001 healthy volunteers, Neurology, 44, 964, 10.1212/WNL.44.5.964

Von Frenckell, 1981, Reparametrisation of the Beck-Pichot Depression Inventory. A contribution to optimal scaling, J Psy Biol Ther, 1, 34

Cardebat, 1990, Evocation lexicale formelle et sémantique chez des sujets normaux. Performances et dynamiques de production en fonction du sexe, de l’âge et du niveau d’étude, Acta Neurol Belg, 90, 207

Grober, 1988, Screening for dementia by memory testing, Neurology, 38, 900, 10.1212/WNL.38.6.900

Calicis, 1995

Picton, 1992, The P3 wave of the human event-related potential, J Clin Neurophysiol, 9, 456, 10.1097/00004691-199210000-00002

Kutas, 1977, Augmenting mental chronometry: the P3 as a measure of stimulus evaluation time, Science, 197, 792, 10.1126/science.887923

Magliero, 1984, On the dependence of P3 latency on stimulus evaluation processes, Psychophysiology, 21, 171, 10.1111/j.1469-8986.1984.tb00201.x

Garcia-Larrea, 1992, Unmasking of cortical SEP components by change in stimulus rate. A topographic study, Electroencephalogr Clin Neurophysiol, 84, 71, 10.1016/0168-5597(92)90069-N

Lemaire, 1993, Nucleophilic enantioselective synthesis of L-6-(18F)Fluoro-l-Dopa via two chiral auxiliaries, J Appl Radiat Isot, 44, 737, 10.1016/0969-8043(93)90141-V

Mazoyer, 1990, Physical characteristics of TTV03, a new high spatial resolution time-of-flight positron tomograph, IEEE Trans Nucl Sci, 37, 778, 10.1109/23.106714

Patlak, 1985, Graphical evaluation of blood to brain transfer constants from multiple time uptake data. Generalizations, J Cereb Blood Flow Metab, 5, 584, 10.1038/jcbfm.1985.87

Takikawa, 1994, Input functions for 6-[Fluorine-18]Fluorodopa quantitation in Parkinsonism: comparative studies and clinical correlations, J Nucl Med, 35, 955

Lee, 1994, Clinical observations on the rate of progression of idiopathic parkinsonism, Brain, 117, 501, 10.1093/brain/117.3.501

Morrish, 1995, Clinical and (18F)dopa PET findings in early Parkinson’s disease, J Neurol Neurosurg Psychiatry, 59, 597, 10.1136/jnnp.59.6.597

Morrish, 1996, An [18F]dopa-PET and clinical study of the rate of progression in Parkinson’s disease, Brain, 119, 585, 10.1093/brain/119.2.585

Eidelberg, 1990, The metabolic anatomy of Parkinson’s disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies, Mov Disord, 5, 203, 10.1002/mds.870050304

Hansch, 1982, Cognition and Parkinson’s disease: an event related perspective, Ann Neurol, 11, 599, 10.1002/ana.410110608

Ruzicka, 1993, Event-related potentials in Parkinson’s disease: a review, Behav Neurol, 6, 15, 10.1155/1993/359534

Bodis-Wollner, 1995, Modality dependent changes in event-related potentials correlate with specific cognitive functions in non-demented patients with Parkinson’s disease, J Neural Transm Par Dis Dement Sect, 9, 197, 10.1007/BF02259661

Rumbach, 1993, Event-related potentials in Parkinson’s disease: a 12-month follow-up study, J Neurol Sci, 116, 148, 10.1016/0022-510X(93)90319-T

Bonnet, 1987, Does long-term aggravation of Parkinson’s disease result from non-dopaminergic lesions?, Neurology, 37, 1539, 10.1212/WNL.37.9.1539